Liver
Liver cancer is a serious disease that develops in the liver cells, with hepatocellular carcinoma (HCC) being the most common type. Risk factors include chronic hepatitis infections, excessive alcohol consumption, and fatty liver disease.
New technique to measure circulating tumor DNA in metastatic cancer may improve surveillance and outcomes
In metastatic cancer surveillance, monitoring the actual concentrations of circulating tumor DNA (ctDNA) may be critical. Researchers showed that absolute ctDNA concentration thresholds can be defined to rule out or predict impending cancer progression.
Experimental vaccine for common cancer shows potential in clinical trial
At Memorial Sloan Kettering Cancer Center (MSK) in New York, an experimental approach to treating the cancer with a messenger RNA (mRNA)-based therapeutic vaccine “continues to show potential” in reducing the risk of the disease returning after surgery, according to a press release.
Groundbreaking Trial Involving 700,000 Women Kicks Off After AI Predicts Breast Cancer Five Years Early
Thousands of women will participate in a study to see if AI could be used for early breast cancer detection. Around 700,000 women in the UK will take part in the AI breast cancer trial, according to the DHSC. Thirty testing sites will be involved in the study, each fitted with groundbreaking AI digital screening technology. Any woman who has already booked a routine breast cancer screening with NHS will be invited to participate in the study.
Blockbuster Weight-Loss Drugs & Cancer Risk: Ozempic Can Affect Pancreas Cells, Experts Weigh In On Whether That’s Worrisome
For people taking GLP-1 drugs, such as the mega-popular weight-loss drug Ozempic (semaglutide) — intended for type 2 diabetes patients and people with obesity — there has been some concern about the effects on the pancreas and whether or not there is a potential risk of pancreatic cancer for people using these medications.
How to lower your risk of skin cancer
GRAND RAPIDS, Mich. (WOOD) — Skin cancer is the most common form of cancer worldwide, and an estimated 1 in 5 Americans develop it by age 70, the Skin Cancer Foundation says. Luckily, there are practical ways to lower your risk of getting it.
Scientists identify feature of aggressive non-small cell lung cancer
In localized non-small cell lung cancer (NSCLC), a tumor’s ability to use carbon from glucose to feed the tricarboxylic acid (TCA) cycle predicts cancer spread beyond the lung, months to years before metastases are clinically apparent.
Innovative molecular therapies target and disrupt uncontrollable growth of cancer cells
wo new studies represent a big step toward developing innovative molecular therapies capable of disrupting the uncontrollable growth of cancers at their roots.
Metastatic cancers: Targeting a protein that fuels treatment-resistant tumors may be key to better outcomes
One of the biggest challenges in cancer treatment is addressing the ability of cancer cells to adapt and become resistant, reducing the effectiveness of therapies over time.
Huntsman Cancer Institute leads the way with advanced robotic surgery technology
Huntsman Cancer Institute at the University of Utah (the U) proudly announces the addition of two da Vinci 5 robotic surgical systems.
Strutting Into Year 11 With Metastatic Breast Cancer
After living with metastatic breast cancer for 11 years, I reflect on my journey and plan to embrace the coming year with confidence and self-advocacy.
Ultra-processed food? Forever chemicals? Declining birth rates? What’s behind rising cancer in the under-50s?
Research into the disease has never been more far-reaching, but there is little consensus as to what is causing the rocketing rates of diagnosis in young adults
